🔴 Abcellera Biologics is trading 4% down today as risk-off selling pressures growth stocks

Abcellera Biologics is trading at $10.60, down 4.07%, as broader risk-off selling pressured growth stocks on September 10, 2026.

• The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are all lower.
• August PPI rose 0.4% monthly and 5.4% annually, reinforcing concerns about inflation and delayed Federal Reserve easing.
• No new company-specific catalyst was identified; the September 9 healthcare conference featured constructive pipeline commentary.